High-altitude diseases (HACE/HAPE)

Respiratory Emergencies

Volumn , Issue , 2006, Pages 253-267

  Grissom, Colin K ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57749171933     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (113)

1. Schoene RB, Hackett PH, Hornbein TF. High altitude. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine,3rd ed.New York:WB Saunders, 2000: 1915-50.
2. Hackett PH, Roach RC. High altitude medicine. In: Auerbach PS, ed. Wilderness Medicine 4th ed. St Louis, MO: Mosby, 2001: 2-43.
3. Sutton JR, Reeves JT, Wagner PD, et al. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 1988; 64: 1309-21.
4. Morris AH, Kanner RE, Crapo RO, Gardner RM. Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures, 2nd ed. Salt Lake City: Intermountain Thoracic Society, 1984.
5. Grissom CK, Schoene RB. Adaptation and maladaptation to high altitude. In: Crapo JD, Glassroth J, Karlinsky J, King TE, Jr, eds. Baums Textbook of Pulmonary Diseases, 7th ed. Philadelphia: Lippincott Williams Wilkins, 2004: 1005-23.
6. Honigman B, Theis MK, Kosiol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118: 587-92.
7. Larson EB, Roach RC, Schoene RB, Hornbein TF. Acute mountain sickness and acetazolamide: Clinical efficacy and effect on ventilation. JAMA 1982; 248: 328-32.
8. Sophocles AM. High-altitude pulmonary edema in Vail, Colorado, 1975-1982. West J Med 1986; 144: 569-73.
9. Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976; 2: 1149-55.
10. Hackett PH, Rennie ID. Rales, peripheral edema, retinal hemorrhage and acute mountain sickness Am J Med 1979; 67:214-18.
11. Hackett PH, Roach RC, Schoene RB, et al. The Denali medical research project, 1982-1985. Am Alpine J 1986; 28: 129-37.
12. Honigman B, Read M, Lezotte D, Roach RC. Sea-level physical activity and acute mountain sickness at moderate altitude. West J Med 1995; 163: 117-21.
13. Bartsch P, Roach R. Acute mountain sickness and high-altitude cerebral edema. In: Hornbein TF, Schoene RB, eds. High Atitude, An Exploration of Human Adaptation. From: Lung Biology in Health and Disease, Lenfant C, exec ed. New York: Marcel Dekker, 2001: 731-76.
14. Pollard AJ, Niermeyer S, Barry P, et al. Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001. High Alt Med Biol 2001; 2:389-403.
15. Roach RC, Houston CS, Honigman B, et al. How well do older persons tolerate moderate altitude? West J Med 1995; 162: 32-6.
16. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004: 5: 36-46.
17. Hackett PH. High altitude cerebral edema and acute mountain sickness: a pathophysiological update. In: Roach RC, Wagner PD, Hackett PH, eds. Hypoxia: Into the Next Millennium, vol. 474 of Advances in Experimental Medicine and Biology. New York: Kluwer Academic/Plenum, 1999: 23-45.
18. Levine BD, Yoshimura K, Kobayashi T, et al. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321: 1707-13.
19. Morocz IA, Zientara GP, Gudbjartsson H, et al. Volumetric quantification of brain swelling after hypobaric hypoxia exposure. Experimental Neurology 2001; 168:96-104.
20. Fischer R, Vollmar C, Thiere M, et al. No evidence of cerebral oedema in severe acute mountain sickness. Cephalagia 2004; 24: 66-71.
21. Bartsch P, Bailey DM, Berger MM, et al. Acute mountain sickness: controversies and advances. High Alt Med Biol 2004; 5: 110-24.
22. Baumgartner RW, Spyridopoulos I, Bartsch P, et al. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J Appl Physiol 1999; 86: 1578-82.
23. Jensen JB, Wright AD, Lassen NA, et al. Cerebral blood flow in acute mountain sickness. J Appl Physiol 1990; 69: 430-3.
24. Singh I, Khanna PK, Srivastava MC, et al. Acute mountain sickness. New Engl J Med 1969; 280: 175-84.
25. Bartsch P, Maggiorini M, Schobersberger W, et al. Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol 1991; 711: 136-43.
26. Hackett PH, Rennie ID, Hofmeiser SE, et al. Fluid retention and relative hypoventilation in acute mountain sickness. Respiration 1982; 43:321-9.
27. Moore LG, Harrison GL, McCullough RE, et al. Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. J Appl Physiol 1986; 60: 1407-12.
28. Sutton JR, Bryan AC, Gray GW, et al. Pulmonary gas exchange in acute mountain sickness. Aviat Space Environ Med 1976; 47: 1032-7.
29. Grissom CK, Roach RC, Sarnquist FH, Hackett PH. Acetazolamide in the treatment of acute mountain sickness: Clinical efficacy and effect on gas exchange. Ann Intern Med 1992; 116:461.
30. Ge Ri-Li, Matsuzawa Y, Takeoka M, et al. Low pulmonary diffusing capacity in subjects with acute mountain sickness. Chest 1997; 111: 58-64.
31. Roach RC, Greene ER, Schoene RB, Hackett PH. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med 1998; 69: 1182-5.
32. Dickinson J, Heath D, Gosney J, Williams D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax 1983; 38: 646-56.
33. Kobayashi T, Koyama S, Kubo K, et al. Clinical features of patients with high altitude pulmonary edema in Japan. Chest 1987; 92: 814-21.
34. Hackett PH, Yarnell PR, Hill R, et al. High altitude cerebral edema evaluated with magnetic resonance imaging, clinical correlation and pathophysiology. JAMA 1998; 280: 1920-5.
35. Roach RC, Bartsch P, Hackett PH, et al. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and Molecular Medicine Burlington, VT: Charles S Houston, 1993: 272-4.
36. Bartsch P, Shaw S, Franciolli M, et al. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 1988; 65: 1929-37.
37. Maggiorini M, Bartsch P, Oelz O. Association between raised body temperature and acute mountain sickness: cross sectional study. BMJ 1997; 315:403-4.
38. Yarnell PR, Heit J, Hackett PH. High altitude cerebral edema (HACE): the Denver/front rang experience. Semin Neurol 2000; 20: 209-17.
39. Hackett PH, Roach RC. High altitude illness. N Engl J Med 2001; 345: 107-14.
40. Purkayastha SS, Ray US, Arora BS, et al. Acclimatization at high altitude in gradual and acute induction. J Appl Physiol 1995; 79: 487-92.
41. Sutton JR, Houston CS, Mansell AL, et al. Effect of acetazolamide on hypoxia during sleep at high altitude. N Engl J Med 1979; 301: 1329-31.
42. Hackett PH, Roach RC, Harrison GL, et al. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 1987; 135: 896-8.
43. Swenson ER, Leatham KL, Roach RC, et al. Renal carbonic anhydrase inhibition reduces high altitude periodic breathing. Respir Physiol 1991; 86: 333-43.
44. Gray GW, Bryan AC, Frayser R, et al. Control of acute mountain sickness. Aerosp Med 1971; 42: 81-4.
45. Greene MK, Kerr AM, McIntosh IB, Prescott RJ. Acetazolamide in prevention of acute mountain sickness: a double blind controlled cross-over study. Br Med J (Clin Res Ed) 1981; 283: 811-13.
46. Dumont L, Mardirosoff C, Tramer MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000; 321:267-72.
47. Gertsch JH, Basnyat B, Johnson EW, et al. Randomized, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 7443: 797.
48. Basnyat B, Gertsch JH, Johnson EW, et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized placebo-controlled trial. High Alt Med Biol 2003; 4: 45-52.
49. Johnson TS, Rock PB, Fulco CS, et al. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984; 310: 683-6.
50. Ellsworth AJ, Meyer EF, Larson EB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mt. Rainier. West J Med 1991;154: 289-93.
51. Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med 1987; 83: 1024.
52. Rock PB, Johnson TS, Larsen RF, et al. Dexamethasone as prophylaxis for acute mountain sickness, effect of dose level. Chest 1989; 95: 568-73.
53. Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988; 59: 950-4.
54. Bernhard WN, Schalick LM, Delaney PA, et al. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. Aviat Space Environ Med 1998; 69: 883-6.
55. Zell SC, Goodman PH. Acetazolamide and dexamethasone in the prevention of acute mountain sickness. West J Med 1988; 148: 541-5.
56. Roncin JP, Schwartz F, D'Arbigny P. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med 1996; 67: 445-52.
57. Maakestad K, Leadbetter G, Olson S, et al. Ginkgo biloba reduces incidence and severity of acute mountain sickness (abstract). Wilderness Environ Med 2001; 12: 51.
58. Gertsch JH, Seto TB, Mor J, Onopa J. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt Med Biol 2002; 3: 29-36.
59. Ferrazzini G, Maggiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone. BMJ 1987; 294: 1380-2.
60. Keller HR, Maggiorini M, Bartsch P, Oelz O. Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial. BMJ 1995; 310: 1232-5.
61. Bartsch P, Merki B, Hofstetter D, et al. Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ 1993; 306: 1098-101.
62. Kasic JF, Yaron M, Nicholas R, et al. Treatment of acute mountain sickness: hyperbaric versus oxygen therapy. Ann Emerg Med 1991; 20: 1109-12.
63. Kayser B, Herry JP, Bartsch P. Pressurization and acute mountain sickness. Aviat Space Environ Med 1993; 64:928-31.
64. Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002; 122: 699-711.
65. The brain trauma foundation. The American Association of Neurological Surgeons. The joint section on neurotrauma and critical care. Critical pathway for the treatment of established intracranial hypertension. J Neurotrauma 2000; 17: 537-8.
66. Gabry AL, Ledoux X, Mozziconacci M, Martin C. High altitude pulmonary edema at moderate altitude (<2400 m; 7870 feet), a series of 52 patients. Chest 2003; 123:49-53.
67. Schoene RB, Swenson ER, Hultgren HN. High altitude pulmonary edema. In: Hornbein TF, Schoene RB, eds. High Altitude, An Exploration of Human Adaptation. From: Lung Biology in Health and Disease, Lenfant C, exec ed. New York: Marcel Dekker, 2001: 777-814.
68. Cremona G, Asnaghi R, Baderna P, et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 2002; 359:303-9.
69. Hanaoka M, Kubo K, Yamazaki Y, et al. Association of high altitude pulmonary edema with the major histocompatibility complex. Circulation 1998; 97:1124-8.
70. Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high altitude pulmonary edema. Circulation 1971; 44: 759-70.
71. Kawashima A, Kubo K, Kobayashi T, Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high altitude pulmonary edema. J Appl Physiol 1989;67: 1982-9.
72. Hackett PH, Roach RC, Schoene RB, et al. Abnormal control of ventilation in high altitude pulmonary edema. J Appl Physiol 1988; 64: 1268-72.
73. Houston CS. Acute pulmonary edema of high altitude. N Engl J Med 1960; 263: 478-80.
74. Hultgren H, Spickard W. Medical experiences in Peru. Stanford Med Bull 1960; 18: 76-95.
75. Hultgren HN, Lopez CE, Lundberg E, Miller H. Physiologic studies of pulmonary edema at high altitude. Circulation 1964; 29: 393-408.
76. Duplain H, Vollenweider L, Delabays A, et al. Augmented sympathetic activation during short term hypoxia and high altitude exposure in subjects susceptible to high altitude pulmonary edema. Circulation 1999; 99: 1713-18.
77. Sartori C, Vollenweider L, Loffler BM, et al. Exaggerated endothelin release in high altitude pulmonary edema. Circulation 1999; 99: 2665-8.
78. Duplain H, Sartori C, Lepori M, et al. Exhaled nitric oxide in high altitude pulmonary edema, role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 2000; 162: 221-4.
79. Busch T, Bartsch P, Pappert D, et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med 2001; 163: 368-73.
80. Hanaoka M, Tanaka M, Ge RL, et al. Hypoxia induced pulmonary blood redistribution in subjects with a history of high altitude pulmonary edema. Circulation 2000; 101: 1418-22.
81. Hackett PH, Creagh CE, Grover RF, et al. High altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 1980; 302: 1070-3.
82. Bartsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991; 325: 1284-9.
83. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996; 334: 624-9.
84. Hackett PH, Roach RC, Hartig GS, et al. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema, a comparison. Int J Sports Med 1992; 13: S68-71.
85. Maggiorini M, Melot C, Pierre S, et al. High altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103: 2078-83.
86. Hultgren HN. High altitude pulmonary edema. In Staub N, ed. Lung Water and Solute Exchange. New York: Marcel Dekker, 1978: 437-69.
87. West JB, Colice GL, Lee YJ, et al. Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J 1995; 8: 523-9.
88. Grissom CK, Albertine KH, Elstad MR. Alveolar haemorrhage in a case of high altitude pulmonary oedema. Thorax 2000; 55: 167-9.
89. Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema, inflammation is not an etiologic factor. JAMA 2002; 287; 2228-35.
90. Schoene RB, Swenson ER, Pizzo CJ, et al. The lung at high altitude, bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J Appl Physiol 1988; 64: 2605-13.
91. Schoene RB, Hackett PH, Henderson WR, et al. High altitude pulmonary edema, characteristics of lung lavage fluid. JAMA 1986; 256: 63-9.
92. Kubo K, Hanaoka M, Yamaguchi S, et al. Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary oedema at moderate altitude in Japan. Thorax 1996; 51: 739-42.
93. Kubo K, Hanaoka M, Hayano T, et al. Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high altitude pulmonary edema. Respir Physiol 1998; 111: 301-10.
94. Kaminsky DA, Jones K, Schoene RB,Voelkel NF. Urinary leukotriene E4 levels in high-altitude pulmonary edema. Chest 1996; 110: 939-45.
95. Bartsch P, Eichenberger U, Ballmer PE, et al. Urinary leukotriene E4 levels are not increased prior to high altitude pulmonary edema. Chest 2000; 117: 1393-8.
96. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346: 1631-6.
97. Grissom CK, Elstad MR. The pathophysiology of high altitude pulmonary edema. Wilderness Environ Med 1999; 10: 88-92.
98. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Resp Dis 1990; 142: 1250-7.
99. Grissom CK, Zimmerman GA, Whatley RE. Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema. Chest 1997; 112: 1572-8.
100. Sakamaki F, Ishizaka A, Handa M, et al. Soluble form of P-selectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med 1995; 151: 1821-6.
101. Ono S, Westcott JY, Chang SW, Viekjek NF. Endotoxin priming followed by high altitude causes pulmonary edema in rats. J Appl Physiol 1993; 74: 1534-42.
102. Stelzner TJ, O'Brien RF, Sato K, et al. Hypoxia-induced increases in pulmonary transvascular protein escape in rats. J Clin Invest 1988; 82: 1840-7.
103. Durmowicz AG, Noordeweir E, Nicholas R, Reeves, JT. Inflammatory processes may predispose children to high-altitude pulmonary edema. J Pediatr 1997; 130: 838-40.
104. Hultgren HN, Wilson R, Kosek JC. Lung pathology in high-altitude pulmonary edema. Wilderness Environ Med 1997; 8:218-20.
105. Hultgren HN, Honigman B, Theis K, Nicholas D. High altitude pulmonary edema at a ski resort. West J Med 1996; 164: 222-7.
106. Vock P, Fretz C, Franciolli M, Bartsch P. High altitude pulmonary edema: findings at high altitude chest radiography and physical examination. Radiology 1989; 170: 661-6.
107. Hultgren HN, Marticorena EA. High altitude pulmonary edema: Epidemiologic observations in Peru. Chest 1978; 74: 372-6.
108. Scoggin CH, Hyers TM, Reeves JT, Grover RF. High altitude pulmonary edema in the children and young adults of Leadville, Colorado. N Engl J Med 1977; 297: 1269-73.
109. Bartsch P. High altitude pulmonary edema. Med Sci Sports Exerc 1999; 31: S23-7.
110. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary edema. Lancet 1989; 2: 1241-4.
111. Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitude and at Mount Everest base camp. Ann Intern Med 2004; 141: 169-77.
112. Hackett PH, Roach RC, Goldberg S, et al. A portable, fabric hyperbaric chamber for treatment of high altitude pulmonary edema [abstract]. In Sutton JR, Coates G, Remmers JE, eds. Hypoxia: The Adaptations. Philadelphia: BC Decker, 1990: 291.
113. Anand IS, Prasad BA, Chugh SS, et al. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation 1998; 98: 2441-5.